Stay updated on GB002 in PAH Clinical Trial
Sign up to get notified when there's something new on the GB002 in PAH Clinical Trial page.

Latest updates to the GB002 in PAH Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe study history now shows a new revision tag, v3.7.0, indicating the record has been updated to a newer version. The previously displayed revision, v3.6.6, is superseded by this update.SummaryDifference0.1%

- Check40 days agoChange DetectedA newer revision label v3.6.6 was added to the record history, replacing the previous v3.6.5; this reflects an update to the study record's versioning.SummaryDifference0.1%

- Check61 days agoChange DetectedA new revision entry v3.6.5 has been added to the record history. The previous revision v3.6.4 has been removed.SummaryDifference0.1%

- Check76 days agoChange DetectedThe sponsor line was updated to Gossamer Bio USA, Inc. (GB002, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.), and the revision tag was updated from v3.6.3 to v3.6.4.SummaryDifference0.1%

- Check97 days agoChange DetectedRevision: v3.6.3 has been added, replacing the previous v3.6.2 in the study history. This represents a minor metadata update to the record rather than changes to study content or participant information.SummaryDifference0.1%

- Check104 days agoChange DetectedThe study record history now includes a new revision entry, Revision: v3.6.2, and removes the older Revision: v3.6.0, updating the page with the latest revision metadata.SummaryDifference0.1%

Stay in the know with updates to GB002 in PAH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GB002 in PAH Clinical Trial page.